For most people health is a choice.
Current testing for cholesterol, triglycerides and insulin are incomplete.
They do not actually do a very good job of predicting your risk for heart disease, diabetes or hypertension
Most doctors are not giving you the information you need to make the best health choices possible!
If you are at risk for:
- Type II Diabetes or are Insulin Resistant
- Coronary Heart Disease
- Have inflammation anywhere in your body
- High cholesterol & triglycerides
- Having a hard time loosing weight
- Low Thyroid function
- Taking a statin (like: Cestor, Lipitor, Zocor a drug to manage glucose & Insulin
- Family history of premature coronary heart disease
- A man over 45 or a woman over 55
You need to take the first step towards wellness.
Our wellness program starts with a free evaluation & consultation to help you take the first steps towards being healthy. We offer a complete approach to wellness.
- We use state of the art testing.
- A comprehensive metabolic profile
- Help with creating a sustainable eating lifestyle designed for your specific needs
- On going nutritional, clinical and life style support
- Needed supplements
Most importantly your health insurance will cover the cost of all the needed testing.
Call today to schedule your free initial consultation and evaluation and start your journey of health and wellness.
Remember, your health insurance will cover the entire cost of the complete metabolic profile.
(It does not matter what your current deductible is)
In addition to an extremely comprehensive test for cholesterol and triglycerides (VAP test) some of the other tests that are included in our metabolic profile include:
High sensitivity C-Reactive Protein (hsCRP) is a nonspecific inflammatory marker produced by the liver in response to inflammatory adipocytokines and macrophages. It is a strong and independent risk marker for primary and secondary CHD events, sudden death, stroke and peripheral vascular disease. Elevation of hsCRP is also associated with insulin resistance and metabolic syndrome.
Lipoprotein-Associated Phospholipase A2 (LpPLA2) is an enzyme responsible for the hydrolysis of oxidized phospholipase on LDL. It is a specific marker for vascular inflammation and is produced in unstable atherosclerotic plaque. Elevated levels indicate a 2 fold increase risk for CVD events and ischemic stroke.
GlycoMark measures I,5 anhydroglucitol (1,5 – AG). It is a nonmetabolized monosaccharide present in small amounts in most foods. I,5 – AG reflects peak glucose levels over 1-2 weeks (short term glucose control). These peaks , not detected by A1C, are associated with the cardiovascular complications of diabetes. 1,5 – AG levels assist in monitoring drug efficacy and treatment alterations including diet and exercise regimens in patients with A1C's at or near goal.
Homocysteine is an amino acid associated with methionine metabolism.
Homocysteinemia is an independent risk factor for primary and secondary CHD events, CHD death, stroke and all cause mortality. Each increase of 5 umol/L in homocysteine level increases the risk of CHD events by approximately 20%, independent of traditional risk factors.
Cystatin C is an enzyme mainly used as a biomarker of renal function. Unlike creatinine, cystatin C is capable of detecting mild decreases in GFR and affected only minimally by age, muscle mass, gender and race. It is also a prognostic marker of CV events, CHF, CVA, PAD, metabolic syndrome and all cause mortality even in the absence of established renal disease.
Gamma-Glutamyl Transferase (GGT) is an enzyme catalyst in the degradation of glutathione, the major antioxidant in the body. GGT is a sensitive proatherogenic, prognostic biomarker for oxidative stress and subclinical atherosclerosis, along with being an independent predictor of metabolic syndrome. Elevated levels are associated with hypertension, insulin resistance, diabetes, obesity, fatty liver and an increase in all cause mortality and morbidity.
N-terminal prohormone BNP (NTproBNP) is a hormone secreted mainly from cardiac monocytes in response to cardiac stress. It is a sensitive biomarker that has powerful prognostic value for detection of subclinical, unsuspected cardiac dysfunction. NTproBNP is an independent predictor of cardiac events and all cause mortality.
Uric acid is the degradation product of purine metabolism. Uric acid elevations are associated with gout, hypertension, metabolic syndrome, CVD, CHF, CVA, dementia, preeclampsia, kidney disease, leukemia and oxidative stress. For every 1 mg/dL increase in serum uric acid, there is a 41% excess risk for mortality. Elevated serum uric acid levels in patients with hypertension are associated with a 3-5 fold increased risk of CAD or CVA.
Vitamin D is a fat soluble vitamin made by ultraviolet light activity on exposed skin. Vitamin D deficiency is associated with a significant graded increased risk for primary and secondary CAD events, PAD, CVA, diabetes and all cause mortality. The Framingham Offspring Study revealed that there was a 1.8X increased risk of CV events when 25(OH) vitamin D levels were < 10 ng/ml. Myalgias from statin therapy may be associated with low vitamin D levels.
Other tests included in the metabolic profile include:
- Thyroid function (more complete then standard medical testing for thyroid health)
- Adrenal health (including: cortisol & DHEA)
- All reproductive hormones (including: estrogen, progesterone, prolactin & testosterone)
- B12 & folate
- Liver function
- Kidney Function
- Iron metabolism
Please call 734-726-0153 to schedule a free consultation and evaluation. At Digestive Health Ann Arbor we are known for providing professional and compassionate care. We strive to guide people towards a comprehensive and holistic healing strategy. Restoring your body to health will restore the quality of your life.